BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Soya S, Sakurai T. Evolution of Orexin Neuropeptide System: Structure and Function. Front Neurosci 2020;14:691. [PMID: 32754010 DOI: 10.3389/fnins.2020.00691] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Alain C, Pascal N, Valérie G, Thierry V. Orexins/Hypocretins and Cancer: A Neuropeptide as Emerging Target. Molecules 2021;26:4849. [PMID: 34443437 DOI: 10.3390/molecules26164849] [Reference Citation Analysis]
2 Lonstein JS, Linning‐duffy K, Tang Y, Moody A, Yan L. Impact of daytime light intensity on the central orexin (hypocretin) system of a diurnal rodent ( Arvicanthis niloticus ). Eur J Neurosci 2021;54:4167-81. [DOI: 10.1111/ejn.15248] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Tanaka S, Seki S, Ono Y, Enomoto A, Kogo M. Persistent sodium conductance contributes to orexin-A-mediated modulation of membrane excitability in neonatal rat mesencephalic V neurons. Neurosci Lett 2021;753:135846. [PMID: 33774148 DOI: 10.1016/j.neulet.2021.135846] [Reference Citation Analysis]
4 Sun Y, Tisdale RK, Kilduff TS. Hypocretin/Orexin Receptor Pharmacology and Sleep Phases. Front Neurol Neurosci 2021;45:22-37. [PMID: 34052813 DOI: 10.1159/000514963] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Couvineau A, Voisin T, Nicole P, Gratio V, Blais A. Orexins: A promising target to digestive cancers, inflammation, obesity and metabolism dysfunctions. World J Gastroenterol 2021; 27(44): 7582-7596 [PMID: 34908800 DOI: 10.3748/wjg.v27.i44.7582] [Reference Citation Analysis]
6 Kobayashi I, Mellman TA, Cannon A, Brown I, Boadi L, Howell MK, Lavela P, Sandhu I. Blocking the orexin system following therapeutic exposure promoted between session habituation, but not PTSD symptom reduction. J Psychiatr Res 2021;145:222-9. [PMID: 34933185 DOI: 10.1016/j.jpsychires.2021.12.027] [Reference Citation Analysis]
7 Fonseca EM, Vicente MC, Fournier S, Kinkead R, Bícego KC, Gargaglioni LH. Influence of light/dark cycle and orexins on breathing control in green iguanas (Iguana iguana). Sci Rep 2020;10:22105. [PMID: 33328521 DOI: 10.1038/s41598-020-79107-2] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Young CE, Tong Q. Corticotropin Releasing Hormone Signaling in the Bed Nuclei of the Stria Terminalis as a Link to Maladaptive Behaviors. Front Neurosci 2021;15:642379. [PMID: 33867924 DOI: 10.3389/fnins.2021.642379] [Reference Citation Analysis]
9 Xu YX, Liu GY, Jiang Q, Bi HQ, Wang SC, Zhang PP, Gao CB, Chen GH, Cheng WH, Chen GJ, Zhu DF, Zhong MK, Xu Q. Effect of Restricted Feeding on Metabolic Health and Sleep-Wake Rhythms in Aging Mice. Front Neurosci 2021;15:745227. [PMID: 34557073 DOI: 10.3389/fnins.2021.745227] [Reference Citation Analysis]
10 Billert M, Rak A, Nowak KW, Skrzypski M. Phoenixin: More than Reproductive Peptide. Int J Mol Sci 2020;21:E8378. [PMID: 33171667 DOI: 10.3390/ijms21218378] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Azeez IA, Igado OO, Olopade JO. An overview of the orexinergic system in different animal species. Metab Brain Dis 2021. [PMID: 34224065 DOI: 10.1007/s11011-021-00761-0] [Reference Citation Analysis]
12 Yu X, Franks NP, Wisden W. Brain Clocks, Sleep, and Mood. Adv Exp Med Biol 2021;1344:71-86. [PMID: 34773227 DOI: 10.1007/978-3-030-81147-1_5] [Reference Citation Analysis]
13 Wang Q, Cao F, Wu Y. Orexinergic System in Neurodegenerative Diseases. Front Aging Neurosci 2021;13:713201. [PMID: 34483883 DOI: 10.3389/fnagi.2021.713201] [Reference Citation Analysis]
14 Bhat US, Shahi N, Surendran S, Babu K. Neuropeptides and Behaviors: How Small Peptides Regulate Nervous System Function and Behavioral Outputs. Front Mol Neurosci 2021;14:786471. [PMID: 34924955 DOI: 10.3389/fnmol.2021.786471] [Reference Citation Analysis]
15 Seoane-Collazo P, Diéguez C, Nogueiras R, Rahmouni K, Fernández-Real JM, López M. Nicotine' actions on energy balance: Friend or foe? Pharmacol Ther 2021;219:107693. [PMID: 32987056 DOI: 10.1016/j.pharmthera.2020.107693] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
16 Roch C, Bergamini G, Steiner MA, Clozel M. Nonclinical pharmacology of daridorexant: a new dual orexin receptor antagonist for the treatment of insomnia. Psychopharmacology (Berl) 2021;238:2693-708. [PMID: 34415378 DOI: 10.1007/s00213-021-05954-0] [Reference Citation Analysis]
17 Xiao X, Yeghiazaryan G, Hess S, Klemm P, Sieben A, Kleinridders A, Morgan DA, Wunderlich FT, Rahmouni K, Kong D, Scammell TE, Lowell BB, Kloppenburg P, Brüning JC, Hausen AC. Orexin receptors 1 and 2 in serotonergic neurons differentially regulate peripheral glucose metabolism in obesity. Nat Commun 2021;12:5249. [PMID: 34475397 DOI: 10.1038/s41467-021-25380-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Revell VL, Della Monica C, Mendis J, Hassanin H, Halter RJ, Chaplan SR, Dijk DJ. Effects of the selective orexin-2 receptor antagonist JNJ-48816274 on sleep initiated in the circadian wake maintenance zone: a randomised trial. Neuropsychopharmacology 2021. [PMID: 34628482 DOI: 10.1038/s41386-021-01175-3] [Reference Citation Analysis]
19 Matzeu A, Martin-fardon R. Understanding the Role of Orexin Neuropeptides in Drug Addiction: Preclinical Studies and Translational Value. Front Behav Neurosci 2022;15:787595. [DOI: 10.3389/fnbeh.2021.787595] [Reference Citation Analysis]